{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:22:20Z","timestamp":1789539740178,"version":"build-2803163510"},"reference-count":23,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.5551\/jat.41483","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T17:21:33Z","timestamp":1516296093000},"page":"580-592","source":"Crossref","is-referenced-by-count":14,"title":["Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan"],"prefix":"10.5551","volume":"25","author":[{"given":"Tamio","family":"Teramoto","sequence":"first","affiliation":[{"name":"Teikyo Academic Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Kai","sequence":"additional","affiliation":[{"name":"Diabetes & Cardiovascular Medical Operations, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Diabetes & Cardiovascular Medical Operations, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Crawford","sequence":"additional","affiliation":[{"name":"Real World Evidence & Insights, inVentiv Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Rinku General Medical Center"},{"name":"Department of Community Medicine & Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Harada-Shiba M, Arai H, Bujo H, Nohara A, Ohta T, Oikawa S, Okada T, Wakatsuki A. Familial Hypercholesterolemia. J Atheroscler Thromb. 2014; 21: 6-10","DOI":"10.5551\/jat.20040"},{"key":"2","unstructured":"2) Japan Atheroscoerlsis Society. Japan Atheroscoerlsis Society (JAS) Guidelines for Prevention of Atherosclerotic Car diovascular Diseases 2017. (in Japanese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Harada T, Inagaki-Tanimura K, Nagao M, Sato Y, Sudo M, Okajima F, Sugihara H, Oikawa S. Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2017; 24: 949-953","DOI":"10.5551\/jat.37770"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E, Tybj\u00e6rg-Hansen A, Watts GF, Averna M, Boileau C, Bor\u00e9n J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AF, Stroes E, Taskinen MR, Wiegman A, Wiklund O, Chapman MJ; European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014; 35: 2146-2157","DOI":"10.1093\/eurheartj\/ehu274"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J; Hokuriku FH Study Group. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011; 214: 404-407","DOI":"10.1016\/j.atherosclerosis.2010.11.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pang J, Lansberg PJ, Watts GF. International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next? J Atheroscler Thromb. 2016; 23: 505-519","DOI":"10.5551\/jat.34108"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mabuchi H. Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan. J Atheroscler Thromb. 2017; 24: 189-207","DOI":"10.5551\/jat.RV16008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Robinson JG. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of managed care pharmacy: J Manag Care Pharm. 2013; 19: 139-149","DOI":"10.18553\/jmcp.2013.19.2.139"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hopkins PN, Toth PP, Ballantyne CM, Rader DJ; National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011; 5: S9-17","DOI":"10.1016\/j.jacl.2011.03.452"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jansen AC, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, van Lennep HW, Sijbrands EJ, Kastelein JJ. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med. 2004; 256: 482-490","DOI":"10.1111\/j.1365-2796.2004.01405.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Alonso R, Mata N, Castillo S, Fuentes F, Saenz P, Mu\u00f1iz O, Galiana J, Figueras R, Diaz JL, Gomez-Enterr\u00eda P, Mauri M, Piedecausa M, Irigoyen L, Aguado R, Mata P; Spanish Familial Hypercholesterolaemia Group. Cardiovascular disease in familial hypercholesterolaemia: influ ence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis. 2008; 200: 315-321","DOI":"10.1016\/j.atherosclerosis.2007.12.024"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mabuchi H, Koizumi J, Shimizu M, Takeda R. Development of coronary heart disease in familial hypercholester olemia. Circulation. 1989; 79: 225-232","DOI":"10.1161\/01.CIR.79.2.225"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S. Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb. 2012; 19: 1043-1060","DOI":"10.5551\/jat.14621"},{"key":"14","unstructured":"14) European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Gra ham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008- 2010 and 2010-2012 Committees. ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32: 1769-1818"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybj\u00e6rg-Hansen A; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34: 3478-3490a","DOI":"10.1093\/eurheartj\/eht273"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Tasaki H, Miyamoto M, Kubara T, Kamezaki F, Tanaka S, Yamashita K, Tsutsui M, Nakashima Y. Cross-Over Trial of Intensive Monotherapy With Atorvastatin and Combined Therapy With Atorvastatin and Colestimide for Japanese Familial Hypercholesterolemia. Circ J. 2005; 70: 14-20","DOI":"10.1253\/circj.70.14"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Harada-Shiba M, Sugisawa T, Makino H, Abe M, Tsushima M, Yoshimasa Y, Yamashita T, Miyamoto Y, Yama moto A, Tomoike H, Yokoyama S. Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. J Atheroscler Thromb. 2010; 17: 667-674","DOI":"10.5551\/jat.4143"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Teramoto T, Kashiwagi A, Mabuchi H, Investigators JL. Status of lipid-lowering therapy prescribedbased on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults: A study of the Japan Lipid Assessment Program (J-LAP). Curr Ther Res Clin Exp. 2005; 66: 80-95","DOI":"10.1016\/j.curtheres.2005.04.004"},{"key":"19","unstructured":"20) Teramoto T. Special Drug Use-Results Survey of Lipitor Tablets (ALWAYS): Interim Report. Therapeutic Research. 2011; 32: 1587-1603"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63: 2889-2934","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T; Research Committeon Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. J Atheroscler Thromb. 2004; 11: 146-151","DOI":"10.5551\/jat.11.146"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Kuiper JG, Sanchez RJ, Houben E, Heintjes EM, Penning-van Beest FJA, Khan I, van Riemsdijk M, Herings RMC. Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands. Clin Ther. 2017; 39: 819-827 e811","DOI":"10.1016\/j.clinthera.2017.03.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Harada-Shiba M, Arai H, Okamura T, Yokote K, Oikawa S, Nohara A, Okada T, Ohta T, Bujo H, Watanabe M, Wakatsuki A, Yamashita S. Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb. 2012; 19: 1019-1026","DOI":"10.5551\/jat.14159"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/7\/25_41483\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T10:37:17Z","timestamp":1570617437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/7\/25_41483\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.41483","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}